Tuesday, June 6, 2023 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

SAN DIEGO - Cadence Pharmaceuticals is selling itself too cheaply through an unfair process to Mallinckrodt, for $14 a share or $1.3 billion, shareholders claim in Superior Court.

Categories: Uncategorized

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.